COMPANY

Sysmex Corporation

Articles that reconnect the numbers in this company’s primary sources into a clearer picture of the business.

Sysmex CorporationFiscal year ended March 2026

From counting blood cells to selling reliable test results.

¥500.0bnFY2025 net sales
¥51.8bnFY2025 operating profit
1965Year the company articulated “selling the results”
What emerges

Sysmex generated ¥500.0bn of net sales and ¥51.8bn of operating profit in FY2025. Its roots lie in Japan's first automated hematology analyzer, commercialized in 1963. In 1965, founder Taro Nakatani expressed the stance of “selling the results.” Academic information followed in 1966, reagents in 1967 and reference materials for quality control in 1968. Sysmex then introduced Japan's first fully automated hematology analyzer in 1975 and what it describes as the world's first fully automated blood cell counter with a sampler in 1979. It later expanded into urinalysis, hemostasis and immunochemistry. Sysmex did not leave instruments behind. It expanded the scope of what it provides around a reliable laboratory result.

See the company through the numbers →